Vaginal Bacteria turn Newborn Skin into Beneficial Bioreactor

How important are the very first microbes we encounter in life?

A fascinating recent article published in Science Magazine highlights how maternal vaginal bacteria transferred at birth may transform newborn skin into a beneficial “bioreactor.” The article discusses emerging evidence that microbes colonizing neonatal skin can produce biologically active metabolites, including lipids that may influence skin physiology and potentially even early brain development. These findings add another important dimension to our understanding of how the first microbial exposures in life may shape long-term health trajectories — especially for babies born by cesarean section.[1].

This connects closely to the pioneering work of José Clemente, Maria Gloria Dominguez-Bello and colleagues on “vaginal seeding”, which is the transfer of maternal vaginal microbiota to cesarean section newborns immediately after birth [2, 3].

Why is this important?

During pregnancy, significant changes occur in the vaginal microbiome. Microbial diversity decreases while Lactobacillus species become dominant [4, 5]. These bacteria maintain a low vaginal pH through the secretion of lactic acid and hydrogen peroxide. This inhibits the growth of pathogenic microorganisms, helping to prevent infections [6, 7]. While scientists suspect this shift is biologically meaningful, many questions remain unanswered:What role do these microbes and their metabolites play in skin maturation, immune education and long-term health?

In the Dominguez-Bello pilot study, sterile gauze was incubated in the vaginas of carefully screened, healthy mothers prior to caesarean section delivery. Immediately after birth, the newborns were swabbed with these vaginal fluids. Over the course of the first month of life, the researchers observed that the microbiome of the infants who had been exposed became increasingly similar to that of babies delivered vaginally, particularly in terms of the skin and oral microbiomes. [2].

Microbes help to train our immune system

This research raises important issues for discussion because caesarean delivery has repeatedly been associated with altered microbiome development and an increased risk of certain immune-related diseases, including: [8-11]:
• asthma [12, 13]
• allergies [14]
• atopic dermatitis [14, 15]
• other potential autoimmune and metabolic disorders [16-18].

Therefore, a healthy microbiome may represent an investment in future health made in early life. From the very beginning of life, microbes help to train our immune system. [19].

Balancing Potential Benefits and Scientific Uncertainties

At the same time, many uncertainties remain.

Long-term studies are urgently needed to determine whether restoring the neonatal microbiome can genuinely reduce the risk of disease later in life [20]. Disrupting the order and timing of colonisation during this critical period of microbiome development could have long-lasting consequences for immune and inflammatory health. Important safety considerations also arise regarding the transfer of potential pathogens, such as Group B Streptococcus and herpes viruses. In Dominguez-Bello's pilot study, only carefully screened, healthy mothers were included to minimise these risks.

Interestingly, newborns are exposed to the same vaginal microbiota, including both beneficial microbes and potentially pathogenic bacteria, during natural vaginal birth [21]. This illustrates the complexity and nuance of the discussion around microbial transfer.

Importantly, this topic is not just about the microbes themselves, but also the metabolites they produce and the biological functions they mediate [22, 23].

There is still a significant lack of knowledge regarding how the composition of the early skin microbiome influences immune and neurological development [24, 25]. In a randomised clinical trial of caesarean-born infants, those who received vaginal microbiota transfer exhibited skin communities at 24 hours that shifted towards profiles seen in infants born via vaginal delivery. These communities were characterised by increased levels of Lactobacillus crispatus and Bacteroides fragilis, as well as an enrichment of sphingolipid and indole-alkaloid pathways. The skin metabolite N-bc2S-1-P, which is formed from two precursor metabolites produced by both L. crispatus and B. fragilis, was found to be higher in caesarean-born infants who received vaginal microbiota transfer than in those in the control group who did not receive transfer. Furthermore, a positive correlation was identified between this metabolite and ASQ 3 neurodevelopmental scores at 3 and 6 months [24]. Understanding these early interactions could be one of the most important areas of research in preventive medicine. Despite mounting evidence in its favour, vaginal seeding is still not standard practice.

However, further information is on the horizon: a large clinical trial led by paediatrician and microbiome researcher Suchitra Hourigan at the National Institute of Allergy and Infectious Diseases is investigating the impact of vaginal seeding on microbiome development and health outcomes in toddlerhood [26].